Dr. Grace Blest-Hopley is a Neuroscientist with a focus on cannabinoids and psychedelics, backed by over 10 years of research experience. She earned her PhD in Neuroscience from King’s College London and is currently the Chief Scientific Officer at NWPharmaTech. Additionally, Dr. Blest-Hopley directs research at the Heroic Hearts Project, a charity supporting combat veterans with mental health challenges from trauma. She is also the founder of Hystelica, a company advancing and advocating for understanding of safe and effective psychedelic use for women.